Ceftriaxone therapy in pediatric patients

Area of Science:

• Pediatric Infectious Diseases
• Pharmacology
• Microbiology

Background:

• Bacterial infections pose a significant threat to pediatric health.
• Intravenous antibiotics are crucial for treating severe pediatric infections.
• Ceftriaxone is a broad-spectrum cephalosporin antibiotic used in children.

Purpose of the Study:

• To evaluate the efficacy and safety of intravenous ceftriaxone sodium in pediatric patients.
• To assess clinical and microbiologic outcomes in children treated with ceftriaxone.
• To identify and document adverse events associated with ceftriaxone therapy in children.

Main Methods:

• A cohort of 26 children (2 months to 15 years) received intravenous ceftriaxone sodium (37.5 mg/kg every 12 hours) for an average of seven days.
• Clinical and microbiologic assessments were performed to determine treatment outcomes.
• Adverse events and laboratory abnormalities were monitored throughout the study.

Main Results:

• Clinical and microbiologic cures were achieved in 19 out of 21 patients with culturable bacterial pathogens.
• Ceftriaxone was ineffective in one case of Staphylococcus aureus periorbital cellulitis and a Salmonella meningitis relapse occurred.
• Common side effects included transient diarrhea (11 patients), superficial candidiasis (10 patients), and asymptomatic laboratory abnormalities (15 patients).

Conclusions:

• Intravenous ceftriaxone sodium demonstrates significant efficacy in treating bacterial infections in pediatric patients.
• The antibiotic is generally well-tolerated, with most adverse events being mild and transient.
• Ceftriaxone is a viable treatment option for pediatric bacterial infections, though resistance and specific cases require careful consideration.